Stocks and InvestingStocks and Investing
Tue, September 7, 2021
Fri, September 3, 2021
Thu, September 2, 2021
Wed, September 1, 2021
Tue, August 31, 2021
Mon, August 30, 2021
Fri, August 27, 2021

Eliana Merle Maintained (BNTX) at Hold with Increased Target to $300 on, Aug 27th, 2021


Published on 2024-10-27 17:47:20 - WOPRAI, Eliana Merle
  Print publication without navigation


Eliana Merle of UBS, Maintained "BioNTech SE" (BNTX) at Hold with Increased Target from $111 to $300 on, Aug 27th, 2021.

Eliana has made no other calls on BNTX in the last 4 months.



There are 6 other peers that have a rating on BNTX. Out of the 6 peers that are also analyzing BNTX, 3 agree with Eliana's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Daina Graybosch of "SVB Leerink" Maintained at Hold with Increased Target to $293 on, Friday, August 13th, 2021
  • Robert Burns of "HC Wainwright & Co." Maintained at Hold with Increased Target to $330 on, Wednesday, August 11th, 2021
  • Chris Shibutani of "Goldman Sachs" Initiated at Hold and Held Target at $173 on, Tuesday, May 18th, 2021


These are the ratings of the 3 analyists that currently disagree with Eliana


  • Arlinda Lee of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $450 on, Friday, August 20th, 2021
  • Olga Smolentseva of "Bryan Garnier" Upgraded from Hold to Strong Buy and Held Target at $451 on, Wednesday, August 11th, 2021
  • Simon Baker of "Redburn Partners" Downgraded from Hold to Strong Sell on, Wednesday, June 16th, 2021